McClay

Robert A. Matthews Joins Leverage IP as Its Patent-Law Expert

Retrieved on: 
Monday, March 6, 2023

Leverage IP , a global consultancy providing holistic IP strategy, unparalleled advising, and creative solutions to help companies benefit financially from their innovations, announced Robert A. Matthews, Jr. has joined the consultancy as its U.S. patent-law expert.

Key Points: 
  • Leverage IP , a global consultancy providing holistic IP strategy, unparalleled advising, and creative solutions to help companies benefit financially from their innovations, announced Robert A. Matthews, Jr. has joined the consultancy as its U.S. patent-law expert.
  • In his new role, Mr. Matthews will work with clients on patent-law issues that may be implicated at any time during the life cycle of patent-related IP.
  • “We are delighted to welcome Bob Matthews to the team at Leverage IP,” said Bob Petrelli, CEO and founder.
  • Matthews, a former registered Professional Engineer, also has several years of engineering experience in the aerospace and nuclear industries.

Aviceda Therapeutics Announces Additional World-Class Members to its Scientific Advisory Board

Retrieved on: 
Monday, September 20, 2021

Aviceda Therapeutics, an IND-stage, pre-clinical biotech company focused on developing the next generation of immuno-modulators by harnessing the power of glycobiology to manipulate the innate immune system and chronic, non-resolving inflammation, is announcing additional members of its Scientific Advisory Board who will help shape ongoing research and development efforts.

Key Points: 
  • Aviceda Therapeutics, an IND-stage, pre-clinical biotech company focused on developing the next generation of immuno-modulators by harnessing the power of glycobiology to manipulate the innate immune system and chronic, non-resolving inflammation, is announcing additional members of its Scientific Advisory Board who will help shape ongoing research and development efforts.
  • The new additional Aviceda Scientific Advisory Board members includes:
    Aviceda is honored and privileged to add new world-class scientists and renowned researchers to join our efforts in developing the next generation of glyco-immune therapeutics for the treatment of immune-dysfunction conditions, said Mohamed A. Genead, MD, Co-Founder & President of Aviceda Therapeutics.
  • She published more than 280 scientific papers in well recognized journals (Cell, Nature, Nature Immunology, PNAS, and JEM) and supervised 29 PhD students.
  • The Aviceda team is already building on the foundational work in the emerging field of glycobiology to develop potential therapeutics and interventional strategies.

Promoting Effective School Leadership, Through TVUSD's Principal Mentoring Program

Retrieved on: 
Tuesday, March 26, 2019

TEMECULA, Calif., March 26, 2019 /PRNewswire-PRWeb/ --A mentoring program introduced by Temecula Valley Unified School District (TVUSD) Deputy Superintendent Jodi McClay provides ongoing leadership support for the district's 27 school principals.

Key Points: 
  • TEMECULA, Calif., March 26, 2019 /PRNewswire-PRWeb/ --A mentoring program introduced by Temecula Valley Unified School District (TVUSD) Deputy Superintendent Jodi McClay provides ongoing leadership support for the district's 27 school principals.
  • In brief, the principal sets the tone for a positive school climate, student development and motivation, academic learning, and quality instruction.
  • "This program has evolved over time," says McClay, "as new principals asked for ongoing mentoring and on-site visitations even after their first two years."
  • Another shared, "The principal mentoring program is extremely helpful!